Comparing the outcomes of noninferiority (NI) and superiority phase III trials.

被引：0
|
作者：
Saad, Everardo D.
Buyse, Marc E.
机构：
[1] Dendrix Res, Sao Paulo, Brazil
[2] Int Inst Drug Dev, Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13055
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A note on comparing two binomial proportions in confirmatory noninferiority trials
    Li, Zhengqing
    Chuang-Stein, Christy
    DRUG INFORMATION JOURNAL, 2006, 40 (02): : 203 - 208
  • [32] Factors associated with altmetric attention scores for randomized phase III cancer clinical trials.
    Rooney, Michael Kevin
    Ludmir, Ethan B.
    Fuller, Clifton Dave
    Warner, Jeremy Lyle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Hypothesis Testing in Superiority, Noninferiority, and Equivalence Clinical Trials Implications in Physical Medicine and Rehabilitation
    Kumbhare, Dinesh
    Alavinia, Mohammad
    Furlan, Julio
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2019, 98 (03) : 226 - 230
  • [34] Virtual superiority: A new composite score for grading the quality of noninferiority cardiovascular clinical trials
    Kaul, Sanjay
    Diamond, George A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 287A - 287A
  • [35] Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?
    Lowenstein, Pedro R.
    Castro, Maria G.
    CURRENT GENE THERAPY, 2009, 9 (05) : 368 - 374
  • [36] The Role of Multiple Imputation in Noninferiority Trials for Binary Outcomes
    Lipkovich, Ilya
    Wiens, Brian L.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2018, 10 (01): : 57 - 69
  • [37] Clinical implications and outcomes of the ORION Phase III trials
    Brandts, Julia
    Ray, Kausik K.
    FUTURE CARDIOLOGY, 2020, 17 (05) : 769 - 777
  • [38] Survival and clinical outcomes of ovarian cancer patients enrolled in phase I clinical trials.
    Corr, Bradley
    Moroney, Marisa
    Sheeder, Jeanelle
    Sawyer, Brandon
    Eckhardt, S. Gail
    Behbakht, Kian
    Diamond, Jennifer Robinson
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] Real-world outcomes of advanced melanoma patients not represented in phase Ill trials.
    Ismail, Rawa
    van Zeijl, Michiel
    De Wreede, Liesbeth
    van den Eertwegh, Alfonsus Johannes Maria
    De Boer, Anthonius
    van Dartel, Maaike
    Hilarius, Doranne
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Boers-Sonderen, Marye
    de Groot, Jan Willem
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Suijkerbuijk, Karijn
    ten Tije, Albert J.
    Van der Veldt, Astrid Aplonia Maria
    Haanen, John B. A. G.
    Wouters, Michel W. J. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Outcomes of patients with gene fusion driven cancers treated on early phase clinical trials.
    Groisberg, Roman
    Hess, Kenneth R.
    Hong, David S.
    Heymach, John
    Naing, Aung
    Piha-Paul, Sarina Anne
    Janku, Filip
    Javle, Milind M.
    Hu, Mimi I-Nan
    Conley, Anthony Paul
    Meric-Bernstam, Funda
    Subbiah, Vivek
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345